Incorporating protein flexibility into docking and structure-based drug design
- 6 September 2006
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 1 (4) , 335-349
Abstract
The use of structure in drug design has become widespread, mainly thanks to recent advances in crystallography. Nevertheless, biological macromolecules are intrinsically flexible and it is increasingly evident that their function depends critically on both their structure and dynamics. In this review the authors discuss the implications of protein flexibility for drug design and review recent progress in incorporating protein flexibility into docking and structure-based drug design.Keywords
This publication has 100 references indexed in Scilit:
- Is one solution good enough?Nature Structural & Molecular Biology, 2006
- Intrinsic dynamics of an enzyme underlies catalysisNature, 2005
- Conformational Changes Observed in Enzyme Crystal Structures upon Substrate BindingJournal of Molecular Biology, 2005
- Soft Docking and Multiple Receptor Conformations in Virtual ScreeningJournal of Medicinal Chemistry, 2004
- Heterogeneity and Inaccuracy in Protein Structures Solved by X-Ray CrystallographyStructure, 2004
- Folding and binding cascades: Dynamic landscapes and population shiftsProtein Science, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Molecular docking to ensembles of protein structures 1 1Edited by B. HonigJournal of Molecular Biology, 1997
- Ligand docking to proteins with discrete side-chain flexibilityJournal of Molecular Biology, 1994
- A geometric approach to macromolecule-ligand interactionsJournal of Molecular Biology, 1982